Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
158 stocks in the Americas match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | Healthcare | $199.23B | 49.40 BRL | −20.09% | +7.95% |
| ABT | Abbott Laboratories | Healthcare | $198.74B | $114.10 | −17.01% | +6.37% |
| GILD | Gilead Sciences, Inc. | Healthcare | $184.47B | $148.09 | −5.85% | +10.25% |
| GILD34.SA | Gilead Sciences, Inc. | Healthcare | $184.15B | 63.72 BRL | −83.92% | −81.50% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| PFIZ34.SA | Pfizer Inc. | Healthcare | $161.53B | 36.48 BRL | −1.59% | +12.73% |
| PFE | Pfizer Inc. | Healthcare | $161.30B | $28.30 | −1.57% | +12.08% |
| DHER34.SA | Danaher Corporation | Healthcare | $151.72B | 39.85 BRL | −13.48% | +9.12% |
| DHR | Danaher Corporation | Healthcare | $151.40B | $215.36 | −11.30% | +8.19% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | Healthcare | $139.70B | 88.56 BRL | −87.17% | +14.82% |
| BMYB34.SA | Bristol-Myers Squibb Company | Healthcare | $138.65B | 349.41 BRL | 0.00% | +12.49% |
| VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $138.63B | $547.29 | −1.51% | +11.60% |
| BMY | Bristol-Myers Squibb Company | Healthcare | $138.03B | $67.57 | −1.56% | +6.24% |
| ISRG | Intuitive Surgical, Inc. | Healthcare | $133.22B | $370.42 | −38.66% | +2.38% |
| I1SR34.SA | Intuitive Surgical, Inc. | Healthcare | $132.60B | 95.28 BRL | −41.38% | +2.14% |
| S1YK34.SA | Stryker Corporation | Healthcare | $126.60B | 84.97 BRL | −20.84% | −3.57% |
| SYK | Stryker Corporation | Healthcare | $126.45B | $329.67 | −16.93% | −4.88% |
| MDTC34.SA | Medtronic plc | Healthcare | $118.37B | 59.52 BRL | −78.53% | +13.44% |
| MDT | Medtronic plc | Healthcare | $117.78B | $92.02 | −13.46% | +5.92% |
| SNY | Sanofi | Healthcare | $108.83B | $45.42 | −13.78% | −0.26% |
| G1SK34.SA | GSK plc | Healthcare | $104.64B | 53.80 BRL | −14.93% | +4.47% |
| M1CK34.SA | McKesson Corporation | Healthcare | $104.59B | 72.17 BRL | −94.48% | +2.08% |
| MCK | McKesson Corporation | Healthcare | $104.54B | $896.65 | −10.25% | +0.80% |
| GSK | GSK plc | Healthcare | $104.29B | $51.43 | −16.65% | −4.25% |
| HCA | HCA Healthcare, Inc. | Healthcare | $94.76B | $427.16 | −23.24% | +2.14% |
| H1CA34.SA | HCA Healthcare, Inc. | Healthcare | $92.89B | 112.22 BRL | −21.56% | +4.87% |
| ELV | Elevance Health, Inc. | Healthcare | $87.30B | $402.54 | −7.73% | +4.36% |
| E1LV34.SA | Elevance Health, Inc. | Healthcare | $86.53B | 410.80 BRL | −5.79% | +3.62% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | Healthcare | $85.16B | 70.98 BRL | −3.20% | +20.22% |
| REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $83.89B | $814.79 | −3.80% | +17.21% |
| CI | The Cigna Group | Healthcare | $74.22B | $280.87 | −10.97% | −6.71% |
| C1IC34.SA | The Cigna Group | Healthcare | $73.39B | 59.58 BRL | −85.67% | −3.85% |
| B1SX34.SA | Boston Scientific Corporation | Healthcare | $70.04B | 62.21 BRL | −89.47% | +4.52% |
| BSX | Boston Scientific Corporation | Healthcare | $69.81B | $48.17 | −56.01% | +4.58% |
| ARGX | argenx SE | Healthcare | $65.51B | $1,047.10 | −1.09% | +20.05% |
| M1RN34.SA | Moderna, Inc. | Healthcare | $63.51B | 38.45 BRL | −14.93% | +173.08% |
| A1RG34.SA | argenx SE | Healthcare | $63.16B | 209.16 BRL | −1.87% | +14.71% |
| COR | Cencora, Inc. | Healthcare | $62.55B | $327.79 | −13.18% | +2.57% |
| MRNA | Moderna, Inc. | Healthcare | $59.75B | $149.66 | −15.28% | +168.18% |
| TAK | Takeda Pharmaceutical Company Limited | Healthcare | $58.60B | $18.23 | −3.54% | +4.05% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | Healthcare | $57.22B | 92.25 BRL | −3.20% | +2.81% |
| C1AH34.SA | Cardinal Health, Inc. | Healthcare | $55.77B | 1,234.64 BRL | −2.94% | +2.68% |
| CAH | Cardinal Health, Inc. | Healthcare | $55.45B | $238.40 | −7.70% | +2.53% |
| C1CO34.SA | Cencora, Inc. | Healthcare | $52.41B | 707.04 BRL | −26.35% | 0.00% |
| EW | Edwards Lifesciences Corporation | Healthcare | $52.32B | $90.78 | −5.72% | +8.48% |
| BDX | Becton, Dickinson and Company | Healthcare | $51.81B | $190.21 | −1.48% | +14.35% |
| B1DX34.SA | Becton, Dickinson and Company | Healthcare | $51.78B | 195.72 BRL | −19.44% | +39.80% |
| NTRA | Natera, Inc. | Healthcare | $48.53B | $338.45 | −0.74% | +34.19% |
| E1WL34.SA | Edwards Lifesciences Corporation | Healthcare | $47.29B | 105.71 BRL | −13.71% | 0.00% |
| HUM | Humana Inc. | Healthcare | $46.96B | $391.06 | −8.82% | +0.60% |
| H1UM34.SA | Humana Inc. | Healthcare | $46.72B | 44.52 BRL | −7.35% | +0.95% |
| MDLN | Medline Inc. | Healthcare | $46.53B | $35.64 | −29.95% | −12.02% |
| RVMD | Revolution Medicines, Inc. | Healthcare | $46.18B | $215.44 | −2.22% | +17.18% |
| HLN | Haleon plc | Healthcare | $44.72B | $10.17 | −9.84% | −0.97% |
| I1DX34.SA | IDEXX Laboratories, Inc. | Healthcare | $44.35B | 572.47 BRL | −29.64% | −0.27% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | Healthcare | $44.24B | 97.74 BRL | 0.00% | +24.04% |
| TEVA | Teva Pharmaceutical Industries Limited | Healthcare | $44.19B | $37.92 | −0.50% | +19.73% |
| A | Agilent Technologies, Inc. | Healthcare | $43.80B | $155.08 | −3.38% | +10.35% |
| IDXX | IDEXX Laboratories, Inc. | Healthcare | $43.66B | $553.44 | −28.12% | −2.83% |
| IQV | IQVIA Holdings Inc. | Healthcare | $43.04B | $261.51 | −0.38% | +7.64% |
| ONC | BeOne Medicines AG | Healthcare | $42.58B | $375.80 | −2.45% | +13.72% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.